NCT04660786

Intralesional Vitamin D in Alopecia Areata

Intralesional Vitamin D3 Injection in Treatment of Alopecia Areata: A Novel Approach

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 10 Years
• Healthy volunteers: Accepted

Summary

To evaluate the efficacy and safety of intralesional injection of vitamin D3 versus intralesional injection of corticosteroids in treatment of alopecia areata. this will be carried out on 40 patients who attend hair outpatient clinic, department of dermatology, Faculty of medicine, Alexandria University, Egypt. The patients will be randomly assigned into two groups (A and B), each group contains 20 patients. Patients will be blindly subjected to intralesional injection of triamcinolone acetonide (5mg/ml) using sterile saline for dilution every 4 weeks for 3 sessions (11,12) or intralesional injection of vitamin D (an aqueous preparation of cholecalciferol (Devarol® ampoule 200,000 IU/2 mL, Memphis, Egypt) (2.5 mg/mL) every 4 weeks for 3 sessions. The maximum total amount of vitamin D3 injected into a patient in 1 session will be 5 mg Injection will be preceded by topical anaesthesia under occlusion for 30 minutes.

Conditions

• Alopecia Areata

Interventions

Type	Name	Description
DRUG	triamcinolone acetonide	local immunosuprresent
DRUG	vitamin D	local immunomodulator

Timeline

• Start date: 2021-11-01
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2020-12-09
• Last updated: 2021-07-26

Locations

1 site across 1 country: Egypt